Sandra Finley

Oct 282018
 

ARISING FROM:

2018-10-23    Vaccinations, Autism: Action Alert. Request USA Dept of Justice to investigate the allegations of fraud & obstruction of justice.

 

—–Original Message—–
From:  Alicia
Sent: October 23, 2018   7:56 PM
Subject: Re: Vaccinations & Autism, a break-through moment?

There have been numerous studies on immunization and autism. You seem to see a correlation although you have no data even for a correlation. Even if there were a significant correlation it doesn’t prove a cause-effect conclusion. A fact doesn’t change just because you don’t believe it.

– – – – – – – – – – – – –

From: Sandra Finley
Sent: October 24, 2018 1:13 PM
I understand what you are saying, Alicia.

In this case, the testimony of the specialists (the doctors who provided the facts) was manipulated, misrepresented, and lied about, by the two Dept of Justice (DOJ, U.S.) lawyers.   The lies became the basis for the court decisions that established “There is no link …”.

This is according to the evidence provided in the “Request for an Investigation”, which is worth reading.  A proper investigation would establish whether the facts provided to the courts were lies or facts.

The APPENDED elaboration may be helpful.  The couple mentioned will be moving to California from Germany, for 3 years (related to their business).  They are expecting a baby, their first, in March.

The vaccination schedule in the U.S. is heavier than it is in Germany.   It starts on day 1 of arrival on Earth.   The parents might, for instance, want the birth to be in Germany, under the German schedule, instead of in the U.S..   If they have information, they have a choice.

/Sandra

– – – – – – – – – – – – –

From: Alicia
Sent: October 24, 2018 3:57 PM

I want “cause-effect” experimental data, not what someone “feels” or “believes”. 

– – – – – – – – – – – – –

From: Sandra Finley
Sent: October 25, 2018 2:08 PM

Hi Alicia,

The CDC had “cause-effect” experimental data.  The data said  “There is a link”.   The top four scientists in the research were assembled and directed to manipulate the data to get a different outcome.   All copies of the original data sets were ordered to be destroyed.  One of the scientists did not comply with the order, and later blew the whistle.

So then we come to the whistleblower, Dr. William Thompson.

 

Thompson is named in the Request for Investigation, the  fourth paragraph from the end.

I think it likely he will be subpoenaed and cross-examined (as should happen), if the Investigation happens.

 

From the Request for Investigation:

 

Justice Scalia had no idea at that time that the government’s epidemiological judgments were the work of Dr. William Thompson (whistleblower) who has confessed to having committed fraud, Dr. Thorsen who the DOJ subsequently indicted for stealing $1 million of vaccine autism research funds, and Thomas Verstraeten, who has disavowed CDC’s characterization of his own study.  At the time the Supreme Court decided this issue, Dr. Thorsen had not yet been indicted, Dr. Thompson had not yet come forward as a whistleblower and the myriad irregularities of the Verstraeten study were still a well-kept secret.

 

There is a video clip of Thompson in this posting:

2016-10-19   the CDC Whistleblower, Dr. William Thompson (Vaccinations and Autism), Related to: Request for Investigation into U.S. Dept of Justice lawyers   

Earlier postings about Thompson:

2016-10-19 CDC Blocks Testimony by Vaccine Whistleblower in Medical Malpractice Case

2017-01-17 Vaccines. No doubt, serious fraud at the CDC. Brian Hooker, William Thompson. How are vaccines made? Henrietta Lacks. Attenuation. Anthrax.

There is important information in this posting – – you can easily verify, for example, that borax is an ingredient in some vaccines.  And the news alert from Health Canada to reduce all exposure of children to borax because of its toxicity.   But they put it in vaccines.

It is not my intention to change your mind about vaccines.

You present an argument:  I want “cause-effect” experimental data, not what someone “feels” or “believes”.

I respect you.   I think it is incumbent upon me to respond if I know that the CDC DID carry out large-scale data analysis.   Thompson’s subsequent whistle-blowing on the efforts that then went into removing some of the data (one of the tactics), in order to obviate the link between the vaccinations and autism are important.

I do not have more to offer.  I think the very best thing that can happen:  a transparent, honest Investigation done by competent people.

Best wishes,

Sandra

– – – – – – – – – – – – –

APPENDED

Hi,

As per our conversation.

 

Martina and Hermann  may be interested.  I am not saying that I know the answers.   I am offering up questions/information they may not be aware of.

 

It is up to you – – to them,  to do your own evaluation.

 

  •  Widely known and accepted, you confirmed:  the vaccine schedule in the U.S. is different than in other countries   (variables such as number of vaccinations received in total, age of infant when vaccinations are started, number of different vaccinations administered at one time, . . . ).

 

(the source of the “Hep B on day 1” and so on, is the official vaccination schedule.  The links to the sources are provided.)

  • The URL below is the document I recommend you read,  the Request for an Investigation (fraud and obstruction of justice).

 

The first reference to the “Vaccine Court” is in the second paragraph.  The U.S. has a “Vaccine Court”;  its purpose is to deal with vaccine injuries.  The rules under which it operates are not the same as in a regular court of law.  Every one of the G-7 countries, except Canada, has some kind of legal process for dealing with vaccine injuries.

The Request for an Investigation quickly gets into the role the different rules in their Vaccine Court played.   It’s “interesting” – – except that, to my way of thinking, (not intentionally) the different rules enabled the fraud, that culminated in  “there is no link . . . “.

The Request for an Investigation is by Robert F Kennedy Jr (as mentioned), and Rolf Hazelhurst (the name I didn’t remember).   Hazelhurst’s son, Yates, was vaccine-injured;  there are before and after home videos of Yates.    Rolf Hazelhurst is an assistant attorney general from Tennessee.

I searched for the above bit of information – – Hazelhurst’s profession – – found it in a document that includes a pretty good description of the Vaccine Court, see APPENDED.   It answers your question about who was prosecuting who, and why.    

        Request for an Investigation   https://childrenshealthdefense.org/child-health-topics/righting-wrongs/request-for-office-of-inspector-general-to-investigate-fraud-and-obstruction-of-justice/

As I say, Martina and Hermann may want to know about the vaccine situation in the U.S.

Also, California passed a law in the last few years, similar to some other U.S. states.   I do not know if there are challenges to it, or if it is being circumvented in some ways:   children may not attend school, public or private, if they have not been fully vaccinated, according to the State’s Schedule of Vaccinations.

/Sandra

APPENDED

The “Vaccine Court”   

If vaccines cause autism, you’d think “vaccine court” would be a great place to find the evidence for it. Compensated claims typically include extensive details about timelines, medical tests, and doctors’ opinions. They read more like case reports in medical journals than legal settlements.

Established through the National Childhood Vaccine Injury Act of 1986, the original purpose of the vaccine court (officially called the United States Court of Federal Claims special masters) was to quickly and expeditiously pay any claims made by American citizens for vaccine injury. The vaccine court is buried within the Department of Health and Human Services (HHS), and when you petition the vaccine court because of a vaccine injury, you’re actually suing the federal government, and the lawyer representing the government (and therefore opposing your claim) will be a Department of Justice lawyer. Due process in vaccine court is nonexistent. there’s no jury, just a single court-appointed “special master” who hears your case and makes a decision.

Since 1989, when the vaccine court began to operate, these special masters have awarded more than $3.8 billion to vaccine-injured Americans (children and adults).4 Of the total cases filed since the court came into existence in 1998, there have been twelve hundred claims filed for death and eighteen thousand filed for injury. The DTP vaccine is the most common vaccine for claims to be filed against, with MMR in second place. Of the people who file claims with the court, approximately 34 percent end up receiving compensation; 2017 was actually the single biggest year for claims paid, with just over $282 million.

Rolf Hazlehurst, an assistant attorney general from Tennessee, has been an outspoken critic of the vaccine court, particularly since he had to fight his way through it as a claimant on behalf of his son Yates, who he believes developed autism as a result of his vaccinations. In a memorandum to the US Congress in 2013, Rolf Hazlehurst described the court:

Vaccine court is not a court of law. It is an administrative proceeding in which the most basic rules of law do not apply. In vaccine court, the Rules of Discovery, Evidence and Civil Procedure do not apply. There is also no judge or jury. In vaccine court, the American legal system has been replaced by what is known as a special master. A special master is an appointed government attorney.5

Why Does the Vaccine Court Exist?

This may seem like an elementary question, but it’s not. The purpose of the vaccine court is to protect the vaccine program, not to monitor vaccine safety or mete out justice. The year the vaccine court began operating—1989—is important to this story, because that’s also the birth year many point to as the beginning of a meteoric rise in the number of children with autism. Three other potentially monumental things happened in 1989: the hepatitis B vaccine was licensed, the Hib vaccine was licensed, and, for the first time, a second dose of the MMR vaccine was recommended for all American children.

When the vaccine court was established in 1986, there were only three vaccines given in the United States—DTP, polio, and MMR—and vaccination rates hovered between 50 and 60 percent nationally.6 Today, there are eleven vaccines for children, given in multiple doses, with vaccination rates hovering around 90 percent nationally. There is an enormous difference between the market the vaccine court was created to “protect” and the market today. In raw numbers there are nearly four times as many vaccine doses given each year to children than there were in 1986, even though the US population has only grown by 0.3 in that same time period.

Beginning in 1989, the US vaccine schedule quickly morphed from the one the vaccine court was created to support to a far larger schedule with more complexity. This isn’t a coincidence; the vaccine court removed all liability from vaccine makers, greatly altering the risk/reward calculation in their favor.

Oct 282018
 
November 28, 2017

High Aluminum Found in Autism Brain Tissue

New Study Indicates that Widespread Exposure to Aluminum Is Setting the Stage for Catastrophic Neurological Damage

Robert F. Kennedy Note: Dr. Christopher Exley’s study is on aluminum in the brains of 10 donors who had autism. They contained some of the highest levels of aluminum ever recorded in human brain, and the aluminum was found in the brain’s immune cells, the microglia and the cells which provide support and protection for the neurons, the glia. How does a 15 year old have as much aluminum in his brain as someone who is many decades older who has died of familial Alzheimer’s disease? Dr. Exley’s findings have shocking implications for today’s generation of children who receive 5,000 mcg. of aluminum in vaccines by the age of 18 months and up to 5,250 additional mcg. if all recommended boosters, HPV and meningitis vaccines are administered.

By the Children’s Health Defense Team

 

Scientists have been aware of aluminum’s neurotoxicity for decades. Although aluminum’s apologists have tried to shroud the metal’s risks in manufactured controversy, a growing number of reports by researchers in the United Kingdom, France, Canada, Israel, the U.S. and elsewhere has furnished substantive evidence linking aluminum to neuropathology, including the epidemics of Alzheimer’s disease (AD) and autism spectrum disorder (ASD).

Aluminum levels were particularly high in the male brains, including in a 15-year-old boy with ASD who had the study’s single highest brain aluminum measurement.

Dr. Christopher Exley—one of the world’s leading experts on aluminum toxicity—has shown that chronic intoxication with myriad forms of this “ubiquitous and omnipresent metal” is exacting a high price on human health. Dr. Exley and other aluminum experts such as molecular biologist Dr. Lucija Tomljenovic have confirmed that aluminum readily and actively traverses the blood-brain barrier to selectively accumulate in brain tissues, where it induces unwelcome changes in brain biochemistry. As Dr. Exley has noted, “There are no ‘normal’ levels of brain aluminum,” meaning that “its presence in brain tissue, at any level, could be construed as abnormal” [emphasis added].

Documenting Aluminum in the ASD Brain

In light of the fact that even minute amounts of aluminum can have adverse neurological consequences, Dr. Exley’s newest paper—which reports on the first-ever study of aluminum in ASD brain tissue—is groundbreaking. Published in the Journal of Trace Elements in Medicine and Biology, the paper documents some of the highest values for aluminum in human brain tissue ever recorded. Using a two-pronged study design (see box), the researchers measured and characterized aluminum deposits in brain tissues from five to ten ASD donors, most of whom died in their teens or twenties.

Study DesignQuantitative component: First, the investigators used graphite furnace atomic absorption spectrometry (GRAAS) to measure aluminum content in frozen brain tissue samples. Frozen tissue was available from one female donor (age 44) and four male donors (ages 15, 22, 33 and 50) who, when alive, had a confirmed ASD diagnosis. The researchers quantified aluminum levels in 59 tissue samples representing five different areas of the brain (frontal, parietal, occipital, temporal and hippocampal).

Qualitative component: Using a technique called fluorescence microscopy, the researchers visualized aluminum deposits according to their presence (a) inside versus outside the brain cells and (b) in the two types of brain tissue (grey matter versus white matter). For this component, fixed tissue samples were available for the same five donors plus an additional five donors diagnosed with ASD, including two females (ages 13 and 29) and three males (ages 14, 22 and 29).

What the research team found was startling. The study’s quantitative arm documented “consistently high” aluminum levels representing “some of the highest values for brain aluminum content ever measured in healthy or diseased tissues.” Specifically:

  • All five individuals had at least one brain tissue with a “pathologically significant” level of aluminum, defined as greater than or equal to 3.00 micrograms per gram of dry brain weight (μg/g dry wt). (Dr. Exley and colleagues developed categories to classify aluminum-related pathology after conducting other brain studies, wherein older adults who died healthy had less than 1 μg/g dry wt of brain aluminum.)
  • Roughly two-thirds (67%) of all the tissue samples displayed a pathologically significant aluminum content.
  • Aluminum levels were particularly high in the male brains, including in a 15-year-old boy with ASD who had the study’s single highest brain aluminum measurement (22.11 μg/g dry wt)—many times higher than the pathologically significant threshold and far greater than levels that might be considered as acceptable even for an aged adult.
  • Some of the elevated aluminum levels rivaled the very high levels historically reported in victims of dialysis encephalopathy syndrome (a serious iatrogenic disorder resulting from aluminum-containing dialysis solutions).

The study’s qualitative findings were equally concerning:

  • Across the 10 donors, the investigators identified 150 aluminum deposits. All 10 donors had aluminum deposits in at least one tissue.
  • Aluminum deposits were markedly more prevalent in males than females (129 deposits in seven males, averaging over 18 deposits each, versus 21 deposits in three females, for an average of 7).
  • In males, most aluminum deposits were inside cells (80/129), whereas aluminum deposits in females were primarily extracellular (15/21). The majority of intracellular aluminum was inside non-neuronal cells (microglia and astrocytes).
  • Aluminum was present in both grey matter (88 deposits) and white matter (62 deposits). (The brain’s grey matter serves to process information, while the white matter provides connectivity.)
  • The researchers also identified aluminum-loaded lymphocytes in the meninges (the layers of protective tissue that surround the brain and spinal cord) and in similar inflammatory cells in the vasculature, furnishing evidence of aluminum’s entry into the brain “via immune cells circulating in the blood and lymph” and perhaps explaining how youth with ASD came to acquire such shockingly high levels of brain aluminum.

The Importance of Glial Cells

There are three broad categories of non-neuronal (glial) cells, including astrocytes (which support neuronal signaling), oligodendrocytes (which create myelin) and microglia (responsible for repairing damage). In discussing their results, Dr. Exley’s team comments that the intracellular location of most of the aluminum in these non-neuronal cells was the “standout observation” for ASD.

…environmental factors can alter microglia function, negatively affecting brain development and synaptic connectivity; when this occurs during important developmental periods, there may be ‘consequences throughout life.’

Unlike other brain cells, the microglia (which represent about 10% of brain cells) are dedicated immune cells. Microglia also play a key role in the process known as synaptic pruning that takes place during vital phases of cognitive development in early childhood as well as adolescence, continuing into the late 20s. This process, which some observers have likened to “neural spring cleaning,” allows the maturing brain to shed “weak or redundant [neuronal] connections.” Given this and other important microglial functions, the microglia have attracted considerable research attention as key players in brain disease, including autism. (Astrocytes also have implications for autism, given the role of astrocyte dysfunction in seizures—a condition that is frequently comorbid with ASD.) A pivotal review article published in 2017 observes that “microglia are now known to be active participants in brain function and dysfunction” and notes that “aberrant [synaptic] pruning during critical developmental periods could contribute to neurodevelopmental disorders.” Evidence suggesting that the microglia are dysfunctional in ASD includes findings from postmortem ASD brain studies showing “altered microglial counts, morphology, and neuronal interaction” as well as altered expression of microglia-specific genes.

It is clear to many researchers that environmental factors can alter microglia function, negatively affecting brain development and synaptic connectivity; when this occurs during important developmental periods, there may be “consequences throughout life.” Aluminum exposure undoubtedly constitutes a dangerous environmental exposure, and Dr. Exley observes that “microglia heavily loaded with aluminum…will inevitably be compromised.”

The Most Pervasive Exposure to Aluminum

The study’s results strongly suggest that aluminum is entering the brain in ASD via cells that have become loaded up with aluminum in the periphery. Where is the aluminum coming from? One of the most pervasive routes of modern-day exposure to neurotoxic aluminum is via aluminum adjuvants in vaccines. (Vaccine manufacturers use aluminum adjuvants to intensify the vaccine recipient’s immune response.) Elsewhere, Dr. Exley has described the “migratory capabilities” of aluminum-based adjuvants “at sites distant to the injection site,” including the brain.

The extreme levels of aluminum found in the brains of the study’s teenage donors have alarming implications for the entire generation of highly aluminum-vaccinated children.

In the ASD brain paper, Dr. Exley and coauthors point out that the “burgeoning” use of aluminum-adjuvant-containing childhood vaccines “has been directly correlated with increasing prevalence of ASD.” A 2011 study by Lucija Tomljenovic and Christopher Shaw confirms that aluminum-containing vaccines are having crippling neurological consequences. Their analysis shows that children from countries where ASD prevalence is highest have the highest exposure to aluminum from vaccines; moreover, children’s increased exposure to aluminum adjuvants over the two decades starting in the 1990s significantly correlates with the increase in ASD prevalence in the U.S.  Counting the shots now pushed during pregnancy, highly vaccinated American children may receive up to 73 total vaccine doses by age 18, including multiple rounds of injected aluminum.

U.S. vaccines containing one or more aluminum adjuvants*

Infection or Illness Vaccine Manufacturer or Brand Name
Diphtheria-tetanus or tetanus-diphtheria DT
Td
Sanofi
Tenivac; Mass Biologics
Diphtheria-tetanus-pertussis or tetanus-diphtheria-pertussis DTaP
Tdap
Daptacel; Infanrix
Adacel; Boostrix
Haemophilus Influenzae type B Hib PedvaxHib
Hepatitis A Hep A Havrix; Vaqta
Hepatitis B Hep B Engerix-B; Recombivax
Human papillomavirus HPV Gardasil; Gardasil 9
Meningitis Meningococcal Bexsero
Streptococcus pneumoniae Pneumococcal PCV 13/Prevnar 13
Combination vaccines DTaP-IPV
DTaP-HepB-IPV
DTaP-IPV/Hib
Hep A/Hep B
Kinrix; Quadracel
Pediarix
Pentacel
Twinrix

* Aluminum hydroxide, aluminum phosphate, aluminum salts, amorphous aluminum hydroxyphosphate sulfate (AAHS), potassium aluminum sulfate

Crucially, Dr. Exley and coauthors note that what “discriminates [their] data from other analyses of brain aluminum in other diseases is the age of the ASD donors” [emphasis added]. The extreme levels of aluminum found in the brains of the study’s teenage donors have alarming implications for the entire generation of highly aluminum-vaccinated children. Moreover, Dr. Exley’s other research has consistently shown that aluminum is the most significant contributing factor to Alzheimer’s disease. Given that it is no longer unheard of to see Alzheimer’s being diagnosed in people who are in their 20s, 30s, or 40s, it is not unreasonable to worry that a catastrophic new wave of AD may be about to compound children’s already heavy burden of ASD and other neurological disorders. Recognizing the risks, numerous researchers have called for a halt to the use of aluminum salts in vaccines. The powerful results of this study underscore the urgency of heeding this plea as well as eliminating exposure to other sources of neurotoxic aluminum.

Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. CHD is planning many strategies, including legal, in an effort to defend the health of our children and obtain justice for those already injured. Your support is essential to CHD’s successful mission.
Oct 282018
 

With thanks to the blog  https://www.jeffereyjaxen.com/

A Book Every Parent In America Is Reading

Note  (Sandra speaking);

I believe the book “How to End the Autism Epidemic”   was sent to:

  •  the Inspector General for the  American Dept of Justice
  •  the Senate Committee on the Dept of Justice
  •  the House Committee on the Dept of Justice
I regret I am unable to find where it was that I read or heard (video) it.

/Sandra

Picture

“I wish I didn’t have to write this book.” These were the words author J.B. Handley spoke to an over-capacity crowd attending his New Jersey book release event. The book, How to End the Autism Epidemic instantly entered best-seller status on Amazon, a position it held even before its official release, and is being viewed as one of the most complete compendiums telling the real story of autism, its causes mainstream medicine avoids discussing, the rise in its epidemic rates, facts about recovery and much more. In addition, the book has stamped into the public discussion irrefutable truths, at the legal, governmental and scientific levels, showing how our modern-day epidemic rates of childhood autism are being created and parents are purposely being left with little recourse. How to End the Autism Epidemic also doubles as one of the best published summaries to date of science from around the world, found in major journals and authored by world-renowned researchers, explaining the emerging science implicating aluminum adjuvant in the development of autism

When Generation Rescue co-founder Handley decided to take on the task of writing his book, he didn’t know at the time that future events would be set into motion to supercharge the atmosphere around its content and publication. How to End the Autism Epidemic, still unreviewed by any mainstream media publication or outlet, contains two further bombshell revelations. The first is the world’s opening look at the recent deposition of Dr. Stanley Plotkin, widely considered the father of modern American vaccine science. Plotkin’s shocking admissions and their significance to the public’s perception of the entire vaccine industry could be the source of a book in its own right. Handley writes that reading the deposition for the first time was “one of the more satisfying moments in my time as an autism activist.” The second revelation is the fraud and manipulation employed in the US Omnibus Autism Proceeding (OAP) that began in 2002 and concluded in 2009. The OAP was a complex solution offered up as an answer to the claims of autism caused by vaccination that were overwhelming the US vaccine court. Handley writes of the OAP, “…the vaccine court took more than 5,500 claims from parents alleging vaccines caused their child’s autism and put them into a single group. Six “test cases,” which were later narrowed to three, were singled out from these 5,500 claims, and the results of the test cases would impact the totality of claims made in the court.”

Hours before his book launch, Handley sat down for a special interview with Del Bigtree along with author and SiriusXM host Jenny McCarthy, Assistant District Attorney General in Tennessee Rolf Hazlehurst and chairman of Children’s Health Defense Robert F. Kennedy Jr., to discuss, among other things, the events and impact of the fraud that occurred during the OAP and Handley’s new book.

Hazlehurst’s son Yates was the second of the three trial cases during the OAP. Dr. Andrew Zimmerman, a world-leading pediatric neurologist and autism research scientist, claimed in his written testimony at the time that there was “no scientific basis” and “no sound evidence to support a causative relationship” between the MMR vaccine or mercury and autism. However, Dr. Zimmerman’s written testimony was specifically and singularly focused on only one child, Michelle Cedillo. Cedillo vs. HHS was the first of the three test cases, with Hazlehurst being next in line, comprising the OAP. Dr. Zimmerman also expressed his belief that there were rare exceptions in which a vaccine can trigger autism.

In a 2007 conversation with OAP Department of Justice (DOJ) attorney Vincent Matanoski and other DOJ attorneys present, Dr. Zimmerman explained how vaccinations could aggravate an underlying mitochondrial disorder to bring about encephalopathy with features of autism spectrum disorder in certain subsets of children. The DOJ-Zimmerman conversation occurred on a Friday [June 15th.] Dr. Zimmerman was expected to testify in the Hazlehurst case on Monday [June 18th.] However, on Sunday, the day before his scheduled testimony, he was called and told he was no longer needed. Yet the DOJ went on to use Dr. Zimmerman’s singular, written testimony meant only for the Cedillo case as the backbone to argue vaccines don’t cause autism in the remaining test cases. There was no opportunity for cross-examination and the DOJ attorneys did not tell the judge that Dr. Zimmerman had additionally including underlying mitochondrial disorders, found to be present in other OAP test cases including Hazlehursts’. It’s interesting to note that years later Dr. Zimmerman’s theory was found to be correlated and the estimate now is that between 25 and 40 percent of children with autism have mitochondrial dysfunction.

In an affidavit Dr. Zimmerman’s writes:

“In my opinion, it was highly misleading for the Department of Justice to continue to use my original written expert opinion, as to Michelle Cedillo, as evidence against the remaining petitioners in the O.A.P.”

A breaking press release by Robert F. Kennedy, Jr and his Children’s Health Defense, is now spotlighting recently discovered evidence of the fraud perpetrated by both DOJ attorneys in the OAP. The press release is demanding the Office of the Inspector General and Congress to investigate the DOJ for fraud and obstruction of justice during the OAP. It states:

“Kennedy and Hazlehurst provide newly discovered evidence that the leading HHS expert, whose written report was used to deny compensation to over 5,000 petitioners in the OAP, provided clarification to the DOJ lawyers that vaccines could, in fact, cause autism in children with underlying and otherwise benign mitochondrial disorders.”

After obtaining depositions and sworn affidavits, Hazlehurst states:

“The DOJ intentionally and fraudulently misrepresented its own expert’s written opinion.  In order to prevent the expert from revealing the truth to other petitioners or the special master these DOJ lawyers canceled the expert’s oral testimony to keep him from stating his true opinion in public. In the process, the DOJ and HHS concealed critical material evidence of how vaccines can cause autism in some children”

In closing, Kennedy summed up the historical results of the OAP and the outcome of the alleged fraud committed by the DOJ during his recent interview with Del Bigtree by stating:

“Because of the fraud by the Justice Department, his [Yates Hazlehurst] case, and 5,400 other cases, Americans, lost their Seventh Amendment right to jury trials. They never got in front of a jury. They never got in front of a court…5,400 people whose children were a national sacrifice were never compensated.”

Oct 262018
 

The Star Phoenix article does not mention the outrage of Canadians over “off-shoring” of taxable income by the wealthy.   The CRA has been taking a kicking;  lobbying didn’t work, so someone started Canadians for Tax Fairness.  Good on them!

Media – the CBC did a good job exposing the CRA,  2016-03-08 Canada Revenue offered amnesty.

Cameco does too much advertising in the Star Phoenix, for it to mention the wrath that might have helped the CRA do the right thing this time around – – an appeal of the Tax Court ruling in favour of Cameco.

Federal authorities demanded secrecy in no-penalty, no-prosecution deal to high net worth Canadians.

So, finally,  . . .

CRA files appeal in multibillion-dollar tax case against Cameco, Saskatoon Star Phoenix

Cameco Corp. says the Canada Revenue Agency is appealing a Tax Court decision that was in the company’s favour. (Photo by THE CANADIAN PRESS)

 

SASKATOON — Cameco Corp. says the Canada Revenue Agency is appealing a Tax Court decision that was in the company’s favour.

The Saskatoon-based uranium miner estimates it will take about two years for the Federal Court of Appeal to hear and decide the case.

Last month, Cameco says the Tax Court ruled its favour in the case which centred around its use of a subsidiary in Switzerland to sell and trade its uranium.

The CRA contended it was a sham established to avoid Canadian taxes, while Cameco maintained it was for legal and sound business practices.

Despite the CRA appeal, Cameco says it will be making an application to the court to recover costs incurred over the course of this case.

Cameco noted that decisions of the Federal Court of Appeal may be appealed to the Supreme Court of Canada, if the top court agrees to hear the appeal.

= = = = =  = = = =

CRA files appeal in multibillion-dollar tax case against Cameco

Cameco executives are “disappointed” that the Canada Revenue Agency is appealing parts of a decision in a multibillion-dollar tax case

Cameco's CEO Tim Gitzel at the Touchdown For Dreams announcement, January 28, 2015. Spokeperson Marilyn Young who will have her 17th treatment for ovarian cancer and says the program is pretty much a wonderful dream in itself.
Cameco CEO Tim Gitzel Gord Waldner / The StarPhoenix
Share Adjust Comment Print

Cameco Corp. says it is “disappointed” that the Canada Revenue Agency chose to appeal a month-old decision that found the company does not have to pay back taxes on $483 million in revenue earned in 2003, 2005 and 2006.

“We hope to have a reasoned discussion with the CRA to see if we can reach a resolution for all years based on the principles laid out in the ruling,” Tim Gitzel, the company’s CEO, said in a statement.

The federal government agency’s appeal is the latest development in its long-running dispute with the Saskatoon-based uranium miner over billions of dollars earned by its European subsidiary over the last 15 years.

In a 293-page decision handed down last month, Tax Court of Canada Justice John Owen ruled that the company was within its rights to use Cameco Europe Limited to report uranium sales earnings in low-tax Switzerland.

Cameco called Owen’s decision a “vindication” of its view that the practice was legal and sound, and suggested it should be applied to the other tax years in question. CRA has issued reassessments for 2003 to 2012, with more expected.

That could lead to $8.4 billion in revenue being moved back to Canada, enough to saddle Cameco with $2.5 billion in taxes and penalties.

In its notice of appeal filed on Oct. 25, the CRA said Own “erred in fact and in law” by finding that the section of the Income Tax Act covering transfer pricing, the business practice Cameco used, did not apply in this case.

In an emailed statement, CRA spokesman Paul Murphy said he was prevented from discussing “the affairs of individual taxpayers,” but noted that the agency is “committed to protecting the tax base by ensuring that all Canadians meet their tax obligations.”

The CRA’s decision is likely to please the local advocacy group Saskatchewan Citizens for Tax Fairness, which has called for an appeal and urged the federal government to close “loopholes” that benefit large corporations.

Devan Mescall, a tax expert at the University of Saskatchewan’s Edwards School of Business, told the Saskatoon StarPhoenix earlier this month that anger about the decision should be channelled into lobbying for clearer rules.

“If you change the rules, the behaviour of these corporations will change as well,” Mescall said.

“We will continue through the appeal process and expect the appeal to be decided in our favour as well,” Gitzel said in the statement, which described Owen’s decision as “clear and decisive” in the company’s favour.

The company said Friday it expects an appeal to take about two years.

amacpherson@postmedia.com
twitter.com/macphersona

Oct 252018
 

CDC Blocks Testimony by Vaccine Whistleblower in Medical Malpractice Case

Thomas Frieden, the director of the Center for Disease Control (CDC), has blocked CDC whistleblower, Dr. William Thompson, from testifying on scientific fraud and destruction of evidence by senior CDC officials in critical vaccine safety studies regarding the causative relationship between childhood vaccines and autism.

The medical malpractice case seeking Dr. Thompson’s testimony is on behalf of 16-year-old Yates Hazlehurst. The lawsuit alleges that Yates is autistic as a result of vaccine injuries.Attorneys Bryan Smith and Robert F. Kennedy, Jr., of Morgan & Morgan, have been seeking to have Dr. Thompson testify in a medical malpractice case to explain how the CDC committed scientific fraud in a series of studies, which found no link between vaccines and autism.

In denying the request, Dr. Frieden said, “Dr. William Thompson’s deposition testimony would not substantially promote the objectives of CDC or HHS [Health and Human Services].”

Dr. Thompson, a 19-year veteran at the CDC and former senior vaccine safety scientist at the agency’s Immunology Safety Office, is the co-author of four key studies that the CDC widely touts to exonerate the MMR vaccine and vaccines containing the mercury-based preservative thimerosal, from being linked to autism. Thompson is currently employed at the CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention.

In August 2014, Dr. Thompson revealed that the data underlying CDC’s principle vaccine safety studies demonstrated a causal link between vaccines and autism or autism symptoms, despite CDC’s claims to the contrary. According to Thompson, based upon interpretation of the data, “There is biologic plausibility right now to say that thimerosal causes autism-like features.” Dr. Thompson invoked federal whistleblower protection in August 2014.

Dr. William Thompson is listed as author or co-author on the principal studies—Thompson, et al. 2007, Price, et al. 2010, Destefano, et al. 2004—most widely cited to “debunk” the link between autism and vaccines. Thompson said that his bosses, including the CDC’s Immunization Safety Office Branch Chief Frank Destefano, specifically ordered him and three other CDC scientists to destroy data demonstrating vaccine induced autism in CDC’s seminal 2004 study—Destefano, et al. 2004. The data unexpectedly showed a 250 percent increase in autism among young black males who received the vaccine on time—before their third birthday—compared to those who waited until after their third birthday. The data also showed a significant link between the vaccine and isolated autism (autism in normally developing children with no other medical problems), the kind suffered by Yates Hazlehurst, who is mentioned below. According to Thompson, Destefano called his four co-authors into a room and ordered them to dump the damning datasets into a giant garbage can. The published study omitted those data sets. That study, now cited in 91 subsequent papers on PubMed as proof of vaccine safety, is the principle foundation stone of the theology that vaccines don’t cause autism.

In a series of taped statements, a deposition to Congressman William Posey of Florida and in statements issued through his personal attorney, Thompson confirmed that the data underlying the seminal 2004 Atlanta study, Destefano, et al. 2004, showed a causal association between MMR and autism for both African-American boys and for children suffering isolated autism. Thompson also asserted that CDC’s leading thimerosal studies, rather than demonstrating thimerosal’s safety, have consistently showed a causal relationship between thimerosal and tics, a family of grave neurological injuries that are a well-established feature of autism.

The medical malpractice case seeking Dr. Thompson’s testimony is on behalf of 16-year-old Yates Hazlehurst. The lawsuit alleges that Yates is autistic as a result of vaccine injuries, which occurred when the vaccines were improperly administered in 2001. Because of the Vaccine Injury Compensation Act of 1986 (VICA), Hazlehurst v. The Jackson Clinic is the only vaccine injury case that has gone to any U.S. court in 30 years.

Under the VICA and the 2009 Supreme Court decision Bruesewitz v. Wyeth, almost all vaccine injured children are barred from filing lawsuits in state or federal courts. Instead, their only legal remedy is to seek compensation under VICA in the so called “vaccine court,” the popular term which refers to the Office of Special Masters of the U.S. Court of Federal Claims, which administers a no-fault system for litigating vaccine injury claims. There is no judge, no jury and the most basic rules of law do not apply.

However, the U. S. Department of Health and Human Services subsequently admitted that during the Omnibus Autism Proceeding it secretly settled and sealed what potentially would have been one of the six test cases, Poling v. HHS after HHS conceded that the vaccines did indeed cause her autism. By conceding the Poling case and opposing the parents motion for complete transparency, HHS concealed critical evidence of how vaccines can cause autism.

Dr. Thompson wants to reveal the scientific fraud and destruction of evidence that took place in the studies that he co-authored. However, in accordance with the Whistle Blower Protection Act and other federal regulations, Dr. Thompson can not testify under oath without the permission of the director of the CDC, Dr. Thomas Frieden.

Hazlehurst’s attorneys, Smith and Kennedy, sought the permission of the CDC to allow Dr. Thompson to testify. The request on behalf of Hazlehurst specifically relates to the issue of causation, i.e. the issue of whether vaccines can cause autism, which the State of Tennessee Circuit Court Judge found to be both relevant and a proper basis for seeking the deposition of Dr. Thompson.

According to Kennedy, who argued before Tennessee Senior Circuit Court Judge William Acree that Dr. Thompson’s testimony was necessary, “Yates, and almost 5,000 other vaccine injured autistic children, lost their cases in vaccine court because CDC and the Justice Department submitted fraudulent science wrongly denying the vaccine-autism link.”

Kennedy explained that Dr. Thompson’s testimony was necessary to explain details of the fraud. “Dr. Thompson will also rebut defense experts’ testimony that Yates was not damaged because vaccines do not cause autism,” Kennedy said.

Accepting the logic of Kennedy’s argument, Judge Acree ordered on Feb. 5 that Dr. Thompson should be deposed. Following Judge’s Acree’s ruling, Smith filed a formal request to CDC to make Thompson available for deposition and trial testimony.

On Sept. 22, in a letter from CDC Director Thomas Freiden, CDC denied Smith’s request. Smith explained that “this denial was a disappointment but not a surprise, since the inescapable implication of Dr. Thompson’s testimony is that the agency fraudulently altered the science to undermine autism cases worth potentially $1 trillion in compensation ordered by Congress.”

Smith and Kennedy plan to immediately appeal the CDC’s denial to federal court.

“Since that original study data is only available from Dr. Thompson,” Smith explained, “We are very confident that a federal judge will order CDC to make Thompson available.”

Show Comments (1)
Oct 232018
 

In response to    2018-10-23   Vaccinations, Autism: Action Alert.

I phoned and then sent the following:

From: Sandra Finley
Sent: October 23, 2018 12:46 PM
To: opr.complaints   AT   usdoj.gov
Subject: Investigation of fraud, obstruction of justice, DOJ & HHS

 

TO:   Corey Amundson, Director

Office of Professional Responsibility (OPR)

Dept of Justice,  USA

opr.complaints@usdoj.gov;  202-514-3365

 

 

Dear Corey Amundson,

 

Please do whatever is within your power to insist that there be an

Investigation of fraud and obstruction of justice,  at the DOJ & HHS.

You will know the details – – Vincent Matanoski,  Lynn Ricciardella  in particular.

 

For a long time I have followed developments related to autism and vaccinations.

My daughter has disabilities;  we have friends whose children have autism.

There are too many parents whose child was progressing normally, then following a vaccination, experienced fever and subsequent regression into autism. I believe my friends.  I know their children, their families.

 

I have looked into the ingredients that are in vaccines.

 

I simply do not believe that there is no link between vaccinations and autism.   The evidence is overwhelmingly to the contrary.   The evidence of corruption is also overwhelming and long standing.

 

The consequences for that injured human being, for their family, for the healthcare system, for our educational systems, for financial survival, is lifelong and  beyond measure.

 

I read the September 20, 2018   Request for Office of Inspector General to Investigate Fraud and Obstruction of Justice   by Robert F Kennedy Jr and Rolf Hazelhurst.

 

The documentation is robust.  It is consistent with what I have learned through the years.   There is more, of course, to the lies and deceptions but an investigation within the parameters set out in the Request has the potential to start a reversal of the relentlessly upward trend in the numbers of children and families being devastated by autism.

 

I will be most appreciative of your efforts on behalf of the goodness that is in all our children,

 

Thank-you.

 

Sandra Finley

Vancouver Island, BC, Canada

Oct 232018
 
 

This is a break-through moment,  in my estimation.  If there’s enough pressure and public awareness to force an investigation, to keep an investigation “clean” and transparent,  we should be able to arrest and reverse the continuous upward trend-line in children with autism.

NOTE:  some of the links show as invalid.   I checked them – – they work just fine.   Haven’t figured out how to fix the way they display.

The   OIG (Office of Inspector General) petition  contains excellent documentation.

  /Sandra

 

Action Alert!
The Office of Inspector General Has Referred RFK, Jr. Allegations of Fraud & Obstruction of Justice to Another Department.
 

Thank you to everyone who called the Office of Inspector General (OIG) Director Horowitz requesting an investigation of the allegations of fraud and obstruction of justice against two Department of Justice (DOJ) lawyers in the Omnibus Autism Proceedings (OAP).

Robert F. Kennedy, Jr. has just received a letter from Deputy Inspector General William Blier regarding the petition stating: “Based on our review, we have determined that your letter contains allegations of misconduct by Department of Justice attorneys in the course of their representing the Department of Health and Human Services in connection with the National Vaccine Injury Compensation Program. Accordingly, we are required by law to refer your allegations to the OPR. We have provided your letter and accompanying materials to OPR for action it determines to be appropriate.”

We need your help! Please contact Corey Amundson, Director, Office of Professional Responsibility (OPR) of the DOJ at 202-514-3365.  Please ask him to investigate the Kennedy/Hazlehurst allegations of fraud and obstruction of justice. Here is the OIG petition and other back-up information for reference. Thank you!

Oct 222018
 
Germany: ‘No basis for positive decisions on arms exports to Saudi Arabia’

German government officials said circumstances Oct. 22 were not supportive of exporting weapons to Saudi Arabia.

BERLIN — In a move that could put further pressure on President Trump to stop arms sales to Saudi Arabia, German Chancellor Angela Merkel announced Sunday evening that her government would not approve new arms exports to the kingdom until further notice.

“There is an urgent need to clarify what happened — we are far from this having been cleared up and those responsible held to account,” she said at a news conference. “I agree with all those who say that the, albeit already limited, arms exports can’t take place in the current circumstances,” Merkel said.

While the move affects future deals, exports that have already been approved to the second-biggest foreign market for German arms equipment will proceed for now but may be suspended in the coming days.

Germany is the first major U.S. ally to cast doubts on future arms sales after the killing of Washington Post contributing columnist Jamal Khashoggi, and the move is likely to put pressure on bigger exporters to do the same. President Trump has ruled out suspending arms exports but faces bipartisan calls to hold the alleged perpetrators behind the writer’s killing accountable.

Since the Oct. 2 disappearance of Khashoggi, companies and governments worldwide have come under pressure to abandon their ties to the Saudi Arabian leadership. Saudi Arabia first denied allegations that it was behind the columnist’s disappearance but later claimed that Khashoggi was killed inside the Saudi Consulate in Istanbul in a “fistfight” with more than a dozen Saudi officials. While Trump has sent mixed messages — both calling the Saudi investigation “credible” and accusing the Saudis of “deception” — key U.S. allies in Europe agree that Riyadh’s explanation does not add up.

Trump says he’s ‘not satisfied’ with Saudi handling of Khashoggi death

Asked during a trip to Nevada, President Trump said he is not satisfied with Saudi Arabia’s handling of the death of journalist Jamal Khashoggi in Istanbul.

On Monday, one of Merkel’s closest allies — Economy Minister Peter Altmaier — pressed other European Union member states to also halt arms sales until they “know what happened.” The German government has said it was seeking to coordinate an international response to the Khashoggi case. But Merkel did not tie her decision to temporarily halt sales to measures taken by other major exporters, including the United States or the more than a dozen other E.U. member states that sell military equipment to the Saudis.

Within the European Union, Britain and France deliver the most equipment to Riyadh, according to the Stockholm International Peace Research Institute. Britain alone sold Saudi Arabia military equipment worth about $1.4 billion in the first six months of last year.

In London, Theresa May’s conservative government has so far been cautious about any sanctions that could endanger thousands of British jobs amid an already strained pre-Brexit economy. Domestic pressure to put human rights first was already growing before Merkel’s announcement on Sunday, with the opposition Labour party calling for a suspension of arms exports to Saudi Arabia.

Germany today accounts for only a relatively small share of European sales to Saudi Arabia, after years of curbing exports to the kingdom amid human rights concerns. Since 2012, the country has substantially reduced exports and toughened its rhetoric against the Saudi leadership, which resulted in the withdrawal of the Saudi ambassador from Berlin and fewer foreign investments from the kingdom.

In the weeks before Khashoggi’s disappearance, however, the German government had backed away from its earlier promise to no longer sell military equipment to the Saudis. In September, it confirmed the export approval of four artillery positioning systems to Riyadh. Overall, Berlin has agreed to export equipment worth more than $460 million to the Saudis this year.

Germany’s announcement on arms exports to Riyadh is yet another policy reversal. Merkel’s critics argue that her shifting stance toward the Saudis leaves her in no good position to lecture other Western leaders on human rights.

While Germany’s complicated dealings with the Saudis raise doubts over the longer-term sustainability of Merkel’s exports ban, her decision still puts other leaders in an uncomfortable position at a sensitive time.

In the United States, a bipartisan group of senators triggered global Magnitsky Act sanctions procedures two weeks ago, forcing Trump to determine possible punishments against Saudi Arabia or Saudi officials over Khashoggi’s killing. If the United States imposed sanctions on Saudi Arabia, other major arms exporters such as Britain would probably also be forced to take similar measures. But in Berlin, top officials hope that their move to suspend future sales could pressure other European allies into following suit, even if the United States refrained from doing so.

Germany’s export stop will have little impact “if at the same time other countries fill this gap,” Merkel’s ally Altmaier acknowledged Monday.

Oct 222018
 

Letter frm Minister McKenna, Nuclear as response to Climate Change

 

This is in response to my letter, March 19, 2018.

Note:  I did not address SMR’s (Small Modular Reactors).   But the response justifies them, too.

2018-03-19 Does Environment Minister McKenna KNOW that Natural Resources Minister Carr is pushing nuclear energy in the UN climate talks, Bonn Germany, May 2018? My letter to the Minister.

 

 

Oct 192018
 
Speculation is mounting that Ecuador is preparing to end its standoff with the British government by terminating Wikileaks founder Julian Assange’s high-profile stay at its embassy

WikiLeaks founder Julian Assange sued the Ecuador government on Friday for violating his “fundamental rights” and limiting his access to the outside world while in asylum at its London embassy.

The 47-year-old Australian’s legal action comes with speculation mounting that Ecuador is preparing to end its standoff with the British government by terminating his high-profile stay.

Assange found refuge in the embassy in 2012 after a British judge ruled he should be extradited to Sweden to face allegations of sexual assault.

That case has since been dropped but Assange fears being extradited to the United States to face charges over the WikiLeaks website’s release of troves of sensitive US government files.

WikiLeaks said its general counsel arrived in Ecuador on Thursday to launch a legal case against the government for “violating (Assange’s) fundamental rights and freedom”.

“The move comes almost seven months after Ecuador threatened to remove his protection and summarily cut off his access to the outside world, including by refusing to allow journalists and human rights organisations to see him,” WikiLeaks said.

It added that the embassy was requiring Assange’s visitors — including journalists and lawyers — to disclose “private or political details such as their social media usernames”.

The Ecuador government issued no immediate statement in response.

Quito confirmed blocking Assange’s internet and mobile phone access in March after accusing him of breaking “a written committment” not to interfere in Ecuador’s foreign policies.

A protocol governing Assange’s stay at the embassy — revealed by Ecuadoran internet site Codigo Vidrio and never denied by Quito — warns that further breaches will lead to “termination of asylum.”

The website reported that the embassy intends to stop paying for Assange’s food and medical care in December.

WikiLeaks lawyer Baltasar Garzon told a press conference in Ecuador on Thursday that Assange’s conditions were “inhuman”.

“It is not a comfortable situation, it is an inhuman situation, because the solution that should already have been reached by the involved states is extending over time,” said the lawyer.

“We have to find a solution, to comply with what is established by the international law and certainly not aggravate the humanitarian situation of an individual, as I say, who is not deprived of liberty.”

Britain’s Press Association news agency said the case is expected to be heard in Ecuador next week.

US Attorney General Jeff Sessions said in March 2017 that arresting Assange for leaking sensitive US government files through his websites was a “priority”.

The legal action comes with speculation mounting that Ecuador was preparing to end its standoff with the British government by terminating Assange’s six-year asylum